EP3548000
ATRÓPÍN LYFJASAMSETNINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.5.2018EP published:
10.11.2021EP application number:
18798073.5
EP translation filed:
27.12.2021Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
9.5.2038Expiry date:
9.5.2026Next due date:
31.5.2026
Title in English:
ATROPINE PHARMACEUTICAL COMPOSITIONSLanguage of the patent:
English
Timeline
Today
10.5.2018EP application
10.11.2021EP Publication
27.12.2021Translation submitted
15.2.2022Registration published
9.5.2026Expires
Owner
Name:
Vyluma Inc.Address:
1019 US Highway 202-206, Bridgewater NJ 08807, US
Inventor
Name:
PURI, NavneetAddress:
Lebanon New Jersey 08833, US
Name:
AKASAPU, Prem SagarAddress:
Edison New Jersey 08817, US
Name:
MOHAMMED, Irfan A.Address:
Picataway NJ 08854, US
Name:
SOPPIMATH, KumareshAddress:
Skillman New Jersey 08558, US
Name:
ILITCHEV, Iouri V.Address:
Hillsborough New Jersey 08844, US
Name:
ZHANG, TaoAddress:
Towaco New Jersey 07082, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201762505027 PDate:
11.5.2017Country:
US
Classification
Categories:
A61K 9/08, A61K 47/38, A61K 47/18, A61K 31/46, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 19.4.2022
Expires: 9.5.2023
Payer: Patice ehf.
Number: 6
Paid: 22.4.2023
Expires: 9.5.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 21.5.2024
Expires: 9.5.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.5.2025
Expires: 9.5.2026
Payer: Árnason Faktor ehf.